Pagano F, Zattoni F, Vianello F
Istituto di Urologia, Università, Padova.
Recenti Prog Med. 1992 Dec;83(12):696-700.
BPH is a very diffuse condition among males increasing in incidence with the age. This explains the large interest in the evaluation of the different strategies concerning BPH treatment. The gold standard has still to be considered the transurethral resection of the prostate which all the other treatments must be compared to. More recently as alternatives to the invasive therapy, so called minimally invasive treatments have been proposed (thermotherapy, prostate dilatation, intraprostatic stents) whose real significance is not completely evaluable yet. As far as medical treatment is concerned, phyto-therapeutic agents have been partially replaced by different substances (alfa- blockers; 5-alfa reductase blockers) that are expected to have a promising future.
良性前列腺增生（BPH）在男性中是一种非常普遍的疾病，其发病率随年龄增长而增加。这就解释了人们对评估BPH不同治疗策略有着浓厚兴趣的原因。经尿道前列腺切除术至今仍被视为金标准，所有其他治疗方法都必须与之进行比较。最近，作为侵入性治疗的替代方法，所谓的微创治疗（热疗、前列腺扩张、前列腺内支架置入）已被提出，但其真正意义尚未完全得到评估。就药物治疗而言，植物治疗剂已部分被不同物质（α受体阻滞剂；5α还原酶抑制剂）所取代，这些物质有望拥有光明的前景。
